Sana Biotechnology (NASDAQ:SANA) Upgraded at Citizens Jmp
Citizens Jmp upgraded shares of Sana Biotechnology (NASDAQ:SANA – Free Report) from a market perform rating to an outperform rating in a report issued on Tuesday, Marketbeat reports. They currently have $5.00 price target on the stock. A number of other equities research analysts have also recently issued reports on SANA. HC Wainwright boosted their […]
Citizens Jmp upgraded shares of Sana Biotechnology (NASDAQ:SANA – Free Report) from a market perform rating to an outperform rating in a report issued on Tuesday, Marketbeat reports. They currently have $5.00 price target on the stock. A number of other equities research analysts have also recently issued reports on SANA. HC Wainwright boosted their […]
